Cancer therapy biotech Heat Biologics files for a $20 million IPO

By
A A A

Heat Biologics, which is developing cellular therapeutic vaccines for cancer therapy, filed on Monday with the SEC to raise up to $20 million in an initial public offering.

The Chapel Hill, NC-based company, which was founded in 2008 and has been awarded $0.6 million in grants since inception, plans to list on the NASDAQ under the symbol HEAX. Heat Biologics initially filed confidentially on December 24, 2012. Aegis Capital is the sole bookrunner on the deal. No pricing terms were disclosed.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: HEAX

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Can You Talk Sexy Money?
Can You Talk Sexy Money?            

Stocks

Referenced

Most Active by Volume

86,692,048
  • $16.82 ▼ 1.35%
66,073,054
  • $13.30 ▼ 6.27%
54,801,491
  • $14.59 ▼ 1.35%
54,305,010
  • $76.55 ▼ 3.15%
53,982,567
  • $3.42 ▼ 2.01%
53,146,472
  • $97.21 ▼ 1.60%
50,334,521
  • $99.18 ▼ 1.56%
44,049,276
  • $25.03 ▼ 0.56%
As of 10/1/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com